Return of genetic and genomic research findings: experience of a pediatric biorepository

[1]  M. Szego,et al.  Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics. , 2019, European journal of medical genetics.

[2]  B. Knoppers,et al.  Return of individual genomic research results: are laws and policies keeping step? , 2019, European Journal of Human Genetics.

[3]  Elizabeth M Webber,et al.  Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group , 2018, Human mutation.

[4]  N. Spinner,et al.  Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study , 2018, Genetics in Medicine.

[5]  H. Mefford,et al.  Return of individual results in epilepsy genomic research: A view from the field , 2018, Epilepsia.

[6]  Daniele Merico,et al.  The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants , 2018, Canadian Medical Association Journal.

[7]  Michelle Mancher,et al.  Returning Individual Research Results to Participants: Guidance for a New Research Paradigm , 2018 .

[8]  Matthew S. Lebo,et al.  A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort , 2017, bioRxiv.

[9]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[10]  J. Botkin.  Ethical issues in pediatric genetic testing and screening , 2016, Current opinion in pediatrics.

[11]  M. Perez,et al.  Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association , 2016, Circulation. Cardiovascular genetics.

[12]  Denise L. Perry,et al.  Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.

[13]  B. Knoppers,et al.  Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process. , 2015, Genome.

[14]  P. P. O'Rourke,et al.  Canadian Research Ethics Board Leadership Attitudes to the Return of Genetic Research Results to Individuals and Their Families , 2015, Journal of Law, Medicine & Ethics.

[15]  P. P. O'Rourke,et al.  Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles , 2015, Journal of Law, Medicine & Ethics.

[16]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[17]  Avni Santani,et al.  Actionable exomic incidental findings in 6503 participants: challenges of variant classification , 2015, Genome research.

[18]  Heidi L Rehm,et al.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between. , 2014, American journal of human genetics.

[19]  R. Dresser.  Public preferences and the challenge to genetic research policy , 2014, Journal of law and the biosciences.

[20]  B. Knoppers,et al.  Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform , 2013, European Journal of Human Genetics.

[21]  B. Knoppers,et al.  Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases , 2013, Journal of Medical Ethics.

[22]  Emily H Turner,et al.  Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.

[23]  Susan M Wolf,et al.  Return of individual research results and incidental findings: facing the challenges of translational science. , 2013, Annual review of genomics and human genetics.

[24]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[25]  B. Knoppers,et al.  Funding considerations for the disclosure of genetic incidental findings in biobank research , 2013, Clinical genetics.

[26]  B. McCrindle,et al.  Impact of Prenatal Risk Factors on Congenital Heart Disease in the Current Era , 2013, Journal of the American Heart Association.

[27]  A. McGuire,et al.  Experiences and Attitudes of Genome Investigators Regarding Return of Individual Genetic Test Results , 2013, Genetics in Medicine.

[28]  M. Bamshad,et al.  Self-guided management of exome and whole-genome sequencing results: changing the results return model , 2013, Genetics in Medicine.

[29]  H. Saal,et al.  Ethical and Policy Issues in Genetic Testing and Screening of Children , 2013, Pediatrics.

[30]  C. Strahlendorf,et al.  Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting , 2013, Genetics in Medicine.

[31]  E. Clayton,et al.  Return of research results from genomic biobanks: cost matters , 2012, Genetics in Medicine.

[32]  B. Knoppers,et al.  Population studies: return of research results and incidental findings Policy Statement , 2012, European Journal of Human Genetics.

[33]  D. Chitayat,et al.  Factors Influencing Participation in a Population-based Biorepository for Childhood Heart Disease , 2012, Pediatrics.

[34]  Robert C. Green,et al.  Managing incidental findings and research results in genomic research involving biobanks and archived data sets , 2012, Genetics in Medicine.

[35]  L. Dressler,et al.  IRB perspectives on the return of individual results from genomic research , 2012, Genetics in Medicine.

[36]  D. Sinnett,et al.  Pediatric Research and the Return of Individual Research Results , 2011, Journal of Law, Medicine & Ethics.

[37]  S. South,et al.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants , 2011, Genetics in Medicine.

[38]  George Church,et al.  Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group , 2010, Circulation. Cardiovascular genetics.

[39]  W. Burke,et al.  Researcher Perspectives on Disclosure of Incidental Findings in Genetic Research , 2010, Journal of empirical research on human research ethics : JERHRE.

[40]  Kenneth D. Mandl,et al.  Reestablishing the Researcher-Patient Compact , 2007, Science.

[41]  Isaac S Kohane,et al.  Medicine. Reestablishing the researcher-patient compact. , 2007, Science.

[42]  C. Weijer,et al.  Considerations and costs of disclosing study findings to research participants , 2004, Canadian Medical Association Journal.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..